Ordering Recommendation

Useful for general screening in contexts of compliance and/or abuse. A screen with reflex testing is the preferred method for ruling out tapentadol exposure. For follow-up testing of a presumptive result, Tapentadol, Urine, Quantitative (2003128) is preferred.

New York DOH Approval Status

This test is New York state approved.

Specimen Required

Patient Preparation
Collect

Random urine.

Specimen Preparation

Transfer 4 mL urine with no additives or preservatives to an ARUP Standard Transport Tube. (Min: 2 mL)

Storage/Transport Temperature

Room temperature.

Unacceptable Conditions

Breast milk. Pharmaceutical preparation. Specimens exposed to repeated freeze/thaw cycles.

Remarks
Stability

Ambient: 1 week: Refrigerated: 1 month; Frozen: 1 month

Methodology

Qualitative Enzyme Immunoassay/Quantitative Liquid Chromatography-Tandem Mass Spectrometry

Performed

Sun-Sat

Reported

1-4 days

Reference Interval

Screen cutoff concentration:   200 ng/mL

Interpretive Data

The absence of expected drug(s) and/or drug metabolite(s) may indicate non-compliance, inappropriate timing of specimen collection relative to drug administration, poor drug absorption, diluted/adulterated urine, or limitations of testing. The concentration at which the screening test can detect a drug or metabolite varies. Specimens for which drugs or drug classes are detected by the screen are reflexed to a second, more specific technology (GC/MS and/or LC-MS/MS). The concentration value must be greater than or equal to the cutoff to be reported as positive. Interpretive questions should be directed to the laboratory.

For medical purposes only; not valid for forensic use.

Compliance Category

Modified FDA

Note

If the specimen screens positive, then Confirmation/Quantitation by LC-MS/MS (ARUP test code 2003128) will be added to confirm result. Additional charges apply.

Hotline History

N/A

CPT Codes

80307; if reflexed, add 80372 (Reflexed Alt Code: G0480 )

Components

Component Test Code* Component Chart Name LOINC
2012212 Screen, Urine Interpretation 54247-2
2012295 Tapentadol, Urn, Screen 72485-6
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.

Aliases

  • Nucynta
  • Tapentadol, Qualitative
Tapentadol Urine Screen with Reflex to Quantitation